Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease
- PMID: 33467995
- PMCID: PMC7893269
- DOI: 10.1098/rspb.2020.1635
Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease
Abstract
Background: it is widely assumed that individuals with Mycobacterium tuberculosis (Mtb) infection remain at lifelong risk of tuberculosis (TB) disease. However, there is substantial evidence that self-clearance of Mtb infection can occur. We infer a curve of self-clearance by time since infection and explore its implications for TB epidemiology. Methods and findings: data for self-clearance were inferred using post-mortem and tuberculin-skin-test reversion studies. A cohort model allowing for self-clearance was fitted in a Bayesian framework before estimating the lifetime risk of TB disease and the population infected with Mtb in India, China and Japan in 2019. We estimated that 24.4% (17.8-32.6%, 95% uncertainty interval (UI)) of individuals self-clear within 10 years of infection, and 73.1% (64.6-81.7%) over a lifetime. The lifetime risk of TB disease was 17.0% (10.9-22.5%), compared to 12.6% (10.1-15.0%) assuming lifelong infection. The population at risk of TB disease in India, China and Japan was 35-80% (95% UI) smaller in the self-clearance scenario. Conclusions: the population with a viable Mtb infection may be markedly smaller than generally assumed, with such individuals at greater risk of TB disease. The ability to identify these individuals could dramatically improve the targeting of preventive programmes and inform TB vaccine development, bringing TB elimination within reach of feasibility.
Keywords: Mycobacterium tuberculosis; epidemiology; infection; mathematical modelling; self-clearance.
Conflict of interest statement
We declare we have no competing interests.
Figures



Similar articles
-
Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis.Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2221186120. doi: 10.1073/pnas.2221186120. Epub 2023 Nov 14. Proc Natl Acad Sci U S A. 2023. PMID: 37963250 Free PMC article.
-
Is neglect of self-clearance biasing TB vaccine impact estimates?BMJ Glob Health. 2023 Aug;8(8):e012799. doi: 10.1136/bmjgh-2023-012799. BMJ Glob Health. 2023. PMID: 37558271 Free PMC article.
-
Is neglect of self-clearance biassing TB vaccine impact estimates?medRxiv [Preprint]. 2023 May 9:2023.04.11.23288400. doi: 10.1101/2023.04.11.23288400. medRxiv. 2023. Update in: BMJ Glob Health. 2023 Aug;8(8):e012799. doi: 10.1136/bmjgh-2023-012799. PMID: 37090535 Free PMC article. Updated. Preprint.
-
Overlooked, dismissed, and downplayed: reversion of Mycobacterium tuberculosis immunoreactivity.Eur Respir Rev. 2024 Jul 24;33(173):240007. doi: 10.1183/16000617.0007-2024. Print 2024 Jul. Eur Respir Rev. 2024. PMID: 39048129 Free PMC article. Review.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
Cited by
-
Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis.Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2221186120. doi: 10.1073/pnas.2221186120. Epub 2023 Nov 14. Proc Natl Acad Sci U S A. 2023. PMID: 37963250 Free PMC article.
-
Achieving a "step change" in the tuberculosis epidemic through comprehensive community-wide intervention: a model-based analysis.BMC Med. 2021 Oct 14;19(1):244. doi: 10.1186/s12916-021-02110-5. BMC Med. 2021. PMID: 34645429 Free PMC article.
-
Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa.PLoS One. 2025 May 9;20(5):e0318819. doi: 10.1371/journal.pone.0318819. eCollection 2025. PLoS One. 2025. PMID: 40343976 Free PMC article.
-
Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy.Front Microbiol. 2021 Oct 22;12:745592. doi: 10.3389/fmicb.2021.745592. eCollection 2021. Front Microbiol. 2021. PMID: 34745048 Free PMC article. Review.
-
After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?Vaccines (Basel). 2021 Dec 31;10(1):57. doi: 10.3390/vaccines10010057. Vaccines (Basel). 2021. PMID: 35062718 Free PMC article. Review.
References
-
- WHO. 2019 Global Tuberculosis Report. 2019. Geneva, Switzerland: World Health Organization; 2019. (13 December 2019).
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical